Lonza to shutter California mammalian clinical facility and lay off 218 staffers
Lonza is closing its mammalian clinical manufacturing facility in Hayward, CA, with 218 employees to be laid off by Feb. 2, a Lonza spokesperson told Endpoints News.
“This decision has been reached as CDMO market demand is focused on combined and integrated clinical-commercial offerings, and the Hayward site provides limited growth opportunities beyond its clinical scope,” the spokesperson added.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.